Infliximab treatment of severe ankylosing spondylitis: one-year followup

Arthritis Rheum. 2001 Dec;44(12):2936-7. doi: 10.1002/1529-0131(200112)44:12<2936::aid-art483>3.0.co;2-m.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antirheumatic Agents / therapeutic use*
  • Follow-Up Studies
  • Humans
  • Infliximab
  • Spondylitis, Ankylosing / therapy*

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Infliximab